Bachem Aktie
WKN: 914589 / ISIN: CH0012530207
18.07.2025 08:28:16
|
Expert Round - Outsourcing in Pharma 2025
The expert panel discussion focused on evolving trends in the pharmaceutical industry, particularly the growing importance of external manufacturing partnerships and supply chain strategies. Representatives from Bachem’s Supply Chain, Global Exclusive APIs, and Business Development for Generics highlighted the strategic shift toward externalization driven by the need for specialized technologies, cost efficiency, speed to market, and risk mitigation.The conversation emphasized the transformation from transactional relationships to long-term, value-driven partnerships between pharmaceutical companies and contract manufacturers (CMOs/CDMOs). Key themes included supply chain robustness, transparency, flexibility, and the integration of customer and supplier operations. The panel also addressed the balance between consolidation and diversification in supplier networks, especially in niche areas like peptides and oligonucleotides.Bachem’s proactive approach to aligning with customer needs through dedicated organizational structures and collaborative practices was presented as a model for future-ready supply chain partnerships.The post Expert Round – Outsourcing in Pharma 2025 appeared first on Bachem.Weiter zum vollständigen Artikel bei Bachem Holding AG

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Bachem AGmehr Nachrichten
Keine Nachrichten verfügbar. |